4//SEC Filing
Boenisch Sandra 4
Accession 0001731122-24-000069
CIK 0001314052other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 8:00 PM ET
Size
5.7 KB
Accession
0001731122-24-000069
Insider Transaction Report
Form 4
Boenisch Sandra
PFO & Treasurer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-02+10,000→ 10,000 totalExercise: $10.09From: 2024-01-02Exp: 2032-06-27→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]On June 27, 2022, the reporting person was granted an option to purchase 40,000 shares of common stock. The option vests in four equal tranches based on four performance milestones, one of which included topline data readout of ANAVEX2-73-RS-003 EXCELLENCE clinical trial in Rett Syndrome. The performance criteria for this milestone was met, resulting in vesting of the option as to 10,000 shares.
Documents
Issuer
ANAVEX LIFE SCIENCES CORP.
CIK 0001314052
Entity typeother
Related Parties
1- filerCIK 0001655366
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 8:00 PM ET
- Size
- 5.7 KB